申请人:Sankyo Company, Limited
公开号:US05908858A1
公开(公告)日:1999-06-01
Compounds of formula (I) and (II): ##STR1## \x9bwherein R is hydrogen, halogen or alkyl; R.sup.1 is alkyl, amino or substituted amino; R.sup.2 is optionally substituted phenyl; R.sup.3 is hydrogen, halogen or optionally substituted alkyl; R.sup.4 is hydrogen, optionally substituted alkyl, cycloalkyl, aryl, or aralkyl! have valuable analgesic, anti-inflammatory, anti-pyretic and anti-allergic activities and have the ability to inhibit the production of leukotrienes and to inhibit bone resorption. They are relatively free from the side effects which generally result from the administration of compounds having these kinds of activities.
化合物的化学式(I)和(II):其中R为氢、卤素或烷基;R.sup.1为烷基、氨基或取代氨基;R.sup.2为可选择取代的苯基;R.sup.3为氢、卤素或可选择取代的烷基;R.sup.4为氢、可选择取代的烷基、环烷基、芳基或芳基烷基!具有宝贵的镇痛、抗炎、退热和抗过敏活性,并具有抑制白三烯产生和抑制骨吸收的能力。它们相对缺乏通常由于使用具有这些活性的化合物而产生的副作用。